BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 03, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Aspirin-PC: Phase II data

In a U.S. Phase II trial in 201 healthy adults ages 50-75, daily PL2200 for 7 days significantly reduced the incidence of gastric and duodenal...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >